{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T22:21:59Z","timestamp":1776464519524,"version":"3.51.2"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003970","name":"Isfahan University of Medical Sciences","doi-asserted-by":"publisher","award":["297134"],"award-info":[{"award-number":["297134"]}],"id":[{"id":"10.13039\/501100003970","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s11033-020-05959-6","type":"journal-article","created":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T20:03:13Z","timestamp":1605038593000},"page":"9013-9019","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Apamin administration impact on miR-219 and miR-155-3p expression in cuprizone induced multiple sclerosis model"],"prefix":"10.1007","volume":"47","author":[{"given":"Samira","family":"Gholami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mina","family":"Mirian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Mehdi","family":"Eftekhari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3416-2596","authenticated-orcid":false,"given":"Mehdi","family":"Aliomrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,10]]},"reference":[{"key":"5959_CR1","doi-asserted-by":"crossref","unstructured":"H\u00f6ftberger R, Lassmann H (2018) Inflammatory demyelinating diseases of the central nervous system. In: Handbook of clinical neurology, vol 145. Elsevier, pp 263\u2013283","DOI":"10.1016\/B978-0-12-802395-2.00019-5"},{"issue":"3","key":"5959_CR2","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/S0303-8467(02)00036-7","volume":"104","author":"M Pugliatti","year":"2002","unstructured":"Pugliatti M, Sotgiu S, Rosati G (2002) The worldwide prevalence of multiple sclerosis. Clin Neurol Neurosurg 104(3):182\u2013191","journal-title":"Clin Neurol Neurosurg"},{"issue":"7745","key":"5959_CR3","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/s41586-018-0842-3","volume":"566","author":"MSY Yeung","year":"2019","unstructured":"Yeung MSY et al (2019) Dynamics of oligodendrocyte generation in multiple sclerosis. Nature 566(7745):538","journal-title":"Nature"},{"issue":"4","key":"5959_CR4","first-page":"825","volume":"15","author":"M Aliomrani","year":"2016","unstructured":"Aliomrani M, Sahraian MA, Shirkhanloo H, Sharifzadeh M, Khoshayand MR, Ghahremani MH (2016) Blood concentrations of cadmium and lead in multiple sclerosis patients from Iran. Iran J Pharm Res 15(4):825","journal-title":"Iran J Pharm Res"},{"issue":"7","key":"5959_CR5","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1007\/s10072-017-2934-5","volume":"38","author":"M Aliomrani","year":"2017","unstructured":"Aliomrani M, Sahraian MA, Shirkhanloo H, Sharifzadeh M, Khoshayand MR, Ghahremani MH (2017) Correlation between heavy metal exposure and GSTM1 polymorphism in Iranian multiple sclerosis patients. Neurol Sci 38(7):1271\u20131278","journal-title":"Neurol Sci"},{"issue":"12","key":"5959_CR6","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1089\/acm.2015.0346","volume":"22","author":"PM Fratellone","year":"2016","unstructured":"Fratellone PM, Tsimis F, Fratellone G (2016) Apitherapy products for medicinal use. J Altern Complement Med 22(12):1020\u20131022","journal-title":"J Altern Complement Med"},{"key":"5959_CR7","unstructured":"Giralt E (2017) Peptides as shuttles for drug delivery to the brain. In: Abstracts of papers of the American Chemical Society, vol 253"},{"issue":"46","key":"5959_CR8","doi-asserted-by":"publisher","first-page":"8868","DOI":"10.1002\/ange.200904550","volume":"121","author":"C Li","year":"2009","unstructured":"Li C, Pazgier M, Liu M, Lu W, Lu W (2009) Apamin as a template for structure-based rational design of potent peptide activators of p53. Angew Chem 121(46):8868\u20138871","journal-title":"Angew Chem"},{"issue":"12","key":"5959_CR9","doi-asserted-by":"publisher","first-page":"4319","DOI":"10.3390\/ijms21124319","volume":"21","author":"J Park","year":"2020","unstructured":"Park J, Jang KM, Park K-K (2020) Apamin suppresses LPS-induced neuroinflammatory responses by regulating SK CHANNELS and TLR4-mediated signaling pathways. Int J Mol Sci 21(12):4319","journal-title":"Int J Mol Sci"},{"issue":"4","key":"5959_CR10","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1073\/pnas.79.4.1308","volume":"79","author":"M Hugues","year":"1982","unstructured":"Hugues M, Romey G, Duval D, Vincent J-P, Lazdunski M (1982) Apamin as a selective blocker of the calcium-dependent potassium channel in neuroblastoma cells: voltage-clamp and biochemical characterization of the toxin receptor. Proc Natl Acad Sci 79(4):1308\u20131312","journal-title":"Proc Natl Acad Sci"},{"key":"5959_CR11","doi-asserted-by":"crossref","unstructured":"Kim S-J et al (2012) The protective effect of apamin on LPS\/fat-induced atherosclerotic mice. Evid-Based Complement Altern Med","DOI":"10.1155\/2012\/305454"},{"issue":"5","key":"5959_CR12","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.3390\/toxins7051749","volume":"7","author":"Y Zhao","year":"2015","unstructured":"Zhao Y et al (2015) Toxins targeting the Kv1. 3 channel: potential immunomodulators for autoimmune diseases. Toxins 7(5):1749\u20131764","journal-title":"Toxins"},{"key":"5959_CR13","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3389\/fphys.2018.00499","volume":"9","author":"JS Valle Reyes","year":"2018","unstructured":"Valle Reyes JS, Valencia Cruz G, Li\u00f1an Rico L, Pottosin I, Dobrovinskaya O (2018) Differential activity of voltage-and Ca2+-dependent potassium channels in leukemic T cell lines: Jurkat cells represent an exceptional case. Front Physiol 9:499","journal-title":"Front Physiol"},{"issue":"676","key":"5959_CR14","first-page":"10","volume":"12","author":"L Thei","year":"2018","unstructured":"Thei L, Imm J, Kaisis E, Dallas ML, Kerrigan TL (2018) Microglia in alzheimer\u2019s disease: a role for ion channels. Front Neurosci 12(676):10\u20133389","journal-title":"Front Neurosci"},{"issue":"12","key":"5959_CR15","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1007\/s11064-019-02892-4","volume":"44","author":"I Bozic","year":"2019","unstructured":"Bozic I et al (2019) The potassium channel Kv1. 5 expression alters during experimental autoimmune encephalomyelitis. Neurochem Res 44(12):2733\u20132745","journal-title":"Neurochem Res"},{"issue":"6","key":"5959_CR16","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1523\/JNEUROSCI.1961-12.2013","volume":"33","author":"PP Maldonado","year":"2013","unstructured":"Maldonado PP, V\u00e9lez-Fort M, Levavasseur F, Angulo MC (2013) Oligodendrocyte precursor cells are accurate sensors of local K+ in mature gray matter. J Neurosci 33(6):2432\u20132442","journal-title":"J Neurosci"},{"issue":"2","key":"5959_CR17","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.aca.2011.05.025","volume":"699","author":"M de Planell-Saguer","year":"2011","unstructured":"de Planell-Saguer M, Rodicio MC (2011) Analytical aspects of microRNA in diagnostics: a review. Anal Chim Acta 699(2):134\u2013152","journal-title":"Anal Chim Acta"},{"issue":"5","key":"5959_CR18","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.neuron.2010.01.027","volume":"65","author":"JC Dugas","year":"2010","unstructured":"Dugas JC et al (2010) Dicer1 and miR-219 Are required for normal oligodendrocyte differentiation and myelination. Neuron 65(5):597\u2013611","journal-title":"Neuron"},{"issue":"5","key":"5959_CR19","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.neuron.2010.02.018","volume":"65","author":"X Zhao","year":"2010","unstructured":"Zhao X et al (2010) MicroRNA-mediated control of oligodendrocyte differentiation. Neuron 65(5):612\u2013626","journal-title":"Neuron"},{"key":"5959_CR20","doi-asserted-by":"crossref","unstructured":"Mazloumfard F, Mirian M, Eftekhari S-M, Aliomrani M (2020) Hydroxychloroquine effects on miR-155\u20133p and miR-219 expression changes in animal model of multiple sclerosis. Metab Brain Dis 1\u20139","DOI":"10.1007\/s11011-020-00609-z"},{"issue":"5","key":"5959_CR21","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/ana.23967","volume":"74","author":"CS Moore","year":"2013","unstructured":"Moore CS et al (2013) miR-155 as a multiple sclerosis\u2013relevant regulator of myeloid cell polarization. Ann Neurol 74(5):709\u2013720","journal-title":"Ann Neurol"},{"key":"5959_CR22","volume-title":"The Allen reference atlas: a digital color brain atlas of the C57Bl\/6J male mouse","author":"HW Dong","year":"2008","unstructured":"Dong HW (2008) The Allen reference atlas: a digital color brain atlas of the C57Bl\/6J male mouse. Wiley, New York"},{"issue":"1","key":"5959_CR23","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nrneurol.2010.179","volume":"7","author":"A Junker","year":"2011","unstructured":"Junker A, Hohlfeld R, Meinl E (2011) The emerging role of microRNAs in multiple sclerosis. Nat Rev Neurol 7(1):56","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"5959_CR24","doi-asserted-by":"publisher","first-page":"6219","DOI":"10.1007\/s11033-011-1441-7","volume":"39","author":"SR Siegel","year":"2012","unstructured":"Siegel SR, Mackenzie J, Chaplin G, Jablonski NG, Griffiths L (2012) Circulating microRNAs involved in multiple sclerosis. Mol Biol Rep 39(5):6219\u20136225","journal-title":"Mol Biol Rep"},{"key":"5959_CR25","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.neuroscience.2017.02.029","volume":"348","author":"J Zhang","year":"2017","unstructured":"Zhang J et al (2017) MiR-146a promotes remyelination in a cuprizone model of demyelinating injury. Neuroscience 348:252\u2013263","journal-title":"Neuroscience"},{"issue":"5","key":"5959_CR26","doi-asserted-by":"publisher","first-page":"424","DOI":"10.4103\/1735-5362.268203","volume":"14","author":"M Mohammadi-Rad","year":"2019","unstructured":"Mohammadi-Rad M, Ghasemi N, Aliomrani M (2019) Evaluation of apamin effects on myelination process in C57BL\/6 mice model of multiple sclerosis. Res Pharm Sci 14(5):424. https:\/\/doi.org\/10.4103\/1735-5362.268203","journal-title":"Res Pharm Sci"},{"issue":"1","key":"5959_CR27","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1159\/000323919","volume":"33","author":"JC Dugas","year":"2011","unstructured":"Dugas JC, Notterpek L (2011) MicroRNAs in oligodendrocyte and Schwann cell differentiation. Dev Neurosci 33(1):14\u201320","journal-title":"Dev Neurosci"},{"key":"5959_CR28","doi-asserted-by":"crossref","unstructured":"McCoy CE (2017) miR-155 dysregulation and therapeutic intervention in multiple sclerosis. In: Regulation of inflammatory signaling in health and disease. Springer,, pp 111\u2013131.","DOI":"10.1007\/978-981-10-5987-2_5"},{"issue":"5","key":"5959_CR29","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/ana.23860","volume":"73","author":"R Dutta","year":"2013","unstructured":"Dutta R et al (2013) Hippocampal demyelination and memory dysfunction are associated with increased levels of the neuronal microRNA miR-124 and reduced AMPA receptors. Ann Neurol 73(5):637\u2013645","journal-title":"Ann Neurol"},{"key":"5959_CR30","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.3389\/fimmu.2018.01256","volume":"9","author":"C Chen","year":"2018","unstructured":"Chen C, Zhou Y, Wang J, Yan Y, Peng L, Qiu W (2018) Dysregulated microRNA involvement in multiple sclerosis by induction of T helper 17 cell differentiation. Front Immunol 9:1256","journal-title":"Front Immunol"},{"issue":"2","key":"5959_CR31","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/ejn.13485","volume":"45","author":"S Liu","year":"2017","unstructured":"Liu S et al (2017) miR-219 attenuates demyelination in cuprizone-induced demyelinated mice by regulating monocarboxylate transporter 1. Eur J Neurosci 45(2):249\u2013259","journal-title":"Eur J Neurosci"},{"issue":"3","key":"5959_CR32","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1002\/jcp.29195","volume":"235","author":"H Yavarpour-Bali","year":"2020","unstructured":"Yavarpour-Bali H, Nakhaei-Nejad M, Yazdi A, Ghasemi-Kasman M (2020) Direct conversion of somatic cells towards oligodendroglial lineage cells: a novel strategy for enhancement of myelin repair. J Cell Physiol 235(3):2023\u20132036","journal-title":"J Cell Physiol"},{"issue":"2","key":"5959_CR33","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s12264-013-1314-2","volume":"29","author":"H Huang","year":"2013","unstructured":"Huang H, Zhao X-F, Zheng K, Qiu M (2013) Regulation of the timing of oligodendrocyte differentiation: mechanisms and perspectives. Neurosci Bull 29(2):155\u2013164","journal-title":"Neurosci Bull"},{"issue":"1\u20132","key":"5959_CR34","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jneuroim.2012.02.012","volume":"246","author":"J Lescher","year":"2012","unstructured":"Lescher J et al (2012) MicroRNA regulation in experimental autoimmune encephalomyelitis in mice and marmosets resembles regulation in human multiple sclerosis lesions. J Neuroimmunol 246(1\u20132):27\u201333","journal-title":"J Neuroimmunol"},{"issue":"1","key":"5959_CR35","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s13311-018-0665-9","volume":"16","author":"RJ Henry","year":"2019","unstructured":"Henry RJ et al (2019) Inhibition of miR-155 limits neuroinflammation and improves functional recovery after experimental traumatic brain injury in mice. Neurotherapeutics 16(1):216\u2013230","journal-title":"Neurotherapeutics"},{"issue":"50","key":"5959_CR36","doi-asserted-by":"publisher","first-page":"16504","DOI":"10.1523\/JNEUROSCI.2830-15.2015","volume":"35","author":"MP Mycko","year":"2015","unstructured":"Mycko MP, Cichalewska M, Cwiklinska H, Selmaj KW (2015) miR-155-3p drives the development of autoimmune demyelination by regulation of heat shock protein 40. J Neurosci 35(50):16504\u201316515","journal-title":"J Neurosci"},{"issue":"1","key":"5959_CR37","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1365-2567.2011.03514.x","volume":"135","author":"AL Cardoso","year":"2012","unstructured":"Cardoso AL, Guedes JR, Pereira de Almeida L, Pedroso de Lima MC (2012) miR-155 modulates microglia-mediated immune response by down-regulating SOCS-1 and promoting cytokine and nitric oxide production. Immunology 135(1):73\u201388","journal-title":"Immunology"},{"issue":"8","key":"5959_CR38","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1073\/pnas.0811073106","volume":"106","author":"M Ceppi","year":"2009","unstructured":"Ceppi M et al (2009) MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. Proc Natl Acad Sci 106(8):2735\u20132740","journal-title":"Proc Natl Acad Sci"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-020-05959-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11033-020-05959-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-020-05959-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T14:35:01Z","timestamp":1605710101000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11033-020-05959-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["5959"],"URL":"https:\/\/doi.org\/10.1007\/s11033-020-05959-6","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"1 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures were approved by the Iran National Committee for Ethics in Biomedical Research (IR.MUI.RESEARCH.REC.1397.387) which was performed in accordance with the Guidelines for the Care and Use of Laboratory Animals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}